ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile

ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
31 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

ALung Technologies, Inc. (ALung) is a medical device company that develops respiratory assist technologies. The company provides respiratory solutions such as respiratory dialysis and hemolung respiratory assist system. Its hemolung respiratory assist system (RAS) allows patients to avoid intubation and mechanical ventilation in various respiratory exacerbation cases. The companys products are used in the treatment of emphysema, chronic bronchitis, asthma with status asthmaticus, acute respiratory failure (ARF), acute respiratory distress syndrome (ARDS), congestive heart failure with pulmonary edema and neonatal respiratory distress syndrome.

ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals

  
Source:
Document ID
GDME1313D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
ALung Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201642
ALung Technologies, Inc., Medical Equipment Deals By Type, 2010 to YTD 201661
ALung Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201671
ALung Technologies, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201681
ALung Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 201691
ALung Technologies, Inc., Medical Equipment, Deal Details109
  Venture Financing101
    ALung Technologies Raises USD12 Million in Financing Round101
    ALung Technologies Raises US$9.5 Million In Venture Financing111
    ALung Technologies Raises US$16 Million In Series B-1 Financing122
    ALung Technologies Raises US$14.7 Million In Venture Financing141
    ALung Technologies Raises Additional US$1 Million In Series B Financing151
    ALung Technologies Secures US$14 Million In Venture Financing161
    ALung Technologies Secures US$2.8 Million In Venture Financing171
    ALung Technologies Raises US$6 Million In Venture Financing181
ALung Technologies, Inc. - Key Competitors191
Key Employees201
Locations And Subsidiaries211
  Head Office211
Recent Developments221
Corporate Communications221
Apr 09, 2015: ALung Appoints David Motley to its Board of Directors221
Product News231
Feb 15, 2016: New study shows promise of ALung s Hemolung technology to help protect the injured lung231
Jun 18, 2015: ALung Technologies Receives CE Mark for New Hemolung XG4 Cartridge Kit241
Jun 18, 2015: ALung Technologies Receives CE Mark for New Hemolung XG4 Catheter Kit251
Apr 23, 2015: The National University Hospital, Singapore Pilots New Clinical Study of the Hemolung RAS Extracorporeal CO2 Removal System261
Feb 12, 2015: ALung Launches Next Generation Extracorporeal CO2 Removal System271
Product Approvals281
Jun 18, 2015: ALung Technologies Receives CE Mark for New Hemolung XG4 Cartridge Kit281
Jun 18, 2015: ALung Technologies Receives CE Mark for New Hemolung XG4 Catheter Kit291
Clinical Trials301
Apr 23, 2015: The National University Hospital, Singapore Pilots New Clinical Study of the Hemolung RAS Extracorporeal CO2 Removal System301
Appendix311
  Methodology311
  About GlobalData311
  Contact Us311
  Disclaimer311

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ALung-Technologies-Inc-Medical-Equipment-Deals-and-Alliances-Profile-2148-10372>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). ALung Technologies, Inc. - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ALung-Technologies-Inc-Medical-Equipment-Deals-and-Alliances-Profile-2148-10372>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research